News Image

Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons

Provided By GlobeNewswire

Last update: May 8, 2025

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, announced the Company has completed its research program as part of the Israel Innovation Authority’s MAGNET incentive program, the Human Robot Interaction Consortium (the “HRI Consortium”). This three-year program provides research and collaboration grants to private businesses and leading academic centers, with the goal of “developing advanced technologies aimed at providing robots with social capabilities, enabling them to carry out various tasks and effective interactions with different users in diverse operational environments.”

Read more at globenewswire.com

LIFEWARD LTD

NASDAQ:LFWD (7/17/2025, 8:00:02 PM)

Premarket: 0.72 -0.02 (-3.17%)

0.7436

+0 (+0.49%)



Find more stocks in the Stock Screener

LFWD Latest News and Analysis

Follow ChartMill for more